Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 132

1.

The evolution of antiplatelet therapy in cardiovascular disease.

Yousuf O, Bhatt DL.

Nat Rev Cardiol. 2011 Jul 12;8(10):547-59. doi: 10.1038/nrcardio.2011.96. Review.

PMID:
21750497
[PubMed - indexed for MEDLINE]
2.

Clinical use of clopidogrel.

Sarafoff N, Byrne RA, Sibbing D.

Curr Pharm Des. 2012;18(33):5224-39. Review.

PMID:
22724411
[PubMed - indexed for MEDLINE]
3.

Emerging antiplatelet therapy for coronary artery disease and acute coronary syndrome.

Packard KA, Campbell JA, Knezevich JT, Davis EM.

Pharmacotherapy. 2012 Mar;32(3):244-73. doi: 10.1002/j.1875-9114.2012.01021.x. Review.

PMID:
22392457
[PubMed - indexed for MEDLINE]
4.

New antiplatelet therapies in development.

Price MJ.

Am J Health Syst Pharm. 2008 Jul 1;65(13 Suppl 5):S11-5; quiz S16-8. doi: 10.2146/ajhp080157.

PMID:
18574020
[PubMed - indexed for MEDLINE]
5.

Antiplatelet therapy prasugrel: a novel platelet ADP P2Y12 receptor antagonist.

Mousa SA, Jeske WP, Fareed J.

Clin Appl Thromb Hemost. 2010 Apr;16(2):170-6. doi: 10.1177/1076029609355589. Review.

PMID:
20299391
[PubMed - indexed for MEDLINE]
6.

Novel platelet ADP P2Y12 inhibitors in the treatment of acute coronary syndrome.

Tan GM, Lam YY, Yan BP.

Cardiovasc Ther. 2012 Aug;30(4):e167-73. doi: 10.1111/j.1755-5922.2011.00262.x. Epub 2011 Jul 31. Review.

PMID:
21883998
[PubMed - indexed for MEDLINE]
7.

Current options in oral antiplatelet strategies during percutaneous coronary interventions.

Tantry US, Gurbel PA.

Rev Cardiovasc Med. 2011;12 Suppl 1:S4-13. Review.

PMID:
22080986
[PubMed - indexed for MEDLINE]
8.

Optimizing antiplatelet therapy following percutaneous coronary intervention: clinical pathways for platelet function testing.

Lassar TA, Simon DI, Croce K.

Rev Cardiovasc Med. 2011;12 Suppl 1:S23-33. Review.

PMID:
22080984
[PubMed - indexed for MEDLINE]
9.

The state of periprocedural antiplatelet therapy after recent trials.

Desai NR, Bhatt DL.

JACC Cardiovasc Interv. 2010 Jun;3(6):571-83. doi: 10.1016/j.jcin.2010.04.008. Review.

PMID:
20630450
[PubMed - indexed for MEDLINE]
Free Article
10.

The future of platelet function testing to guide therapy in clopidogrel low and enhanced responders.

Bernlochner I, Byrne RA, Kastrati A, Sibbing D.

Expert Rev Cardiovasc Ther. 2011 Aug;9(8):999-1014. doi: 10.1586/erc.11.80. Review.

PMID:
21878045
[PubMed - indexed for MEDLINE]
11.

Antiplatelet drugs--do we need new options? With a reappraisal of direct thromboxane inhibitors.

Coccheri S.

Drugs. 2010 May 7;70(7):887-908. doi: 10.2165/11536000-000000000-00000. Review.

PMID:
20426498
[PubMed - indexed for MEDLINE]
12.

The P2Y12 receptor as a therapeutic target in cardiovascular disease.

Storey RF.

Platelets. 2001 Jun;12(4):197-209. Review.

PMID:
11454254
[PubMed - indexed for MEDLINE]
13.

Platelet inhibitors in non-ST-segment elevation acute coronary syndromes and percutaneous coronary intervention: glycoprotein IIb/IIIa inhibitors, clopidogrel, or both?

Silva MA, Donovan JL, Gandhi PJ, Volturo GA.

Vasc Health Risk Manag. 2006;2(1):39-48. Review.

PMID:
17319468
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

ADP receptor antagonism: what's in the pipeline?

Angiolillo DJ.

Am J Cardiovasc Drugs. 2007;7(6):423-32. Review.

PMID:
18076209
[PubMed - indexed for MEDLINE]
15.

Randomized comparison of prasugrel (CS-747, LY640315), a novel thienopyridine P2Y12 antagonist, with clopidogrel in percutaneous coronary intervention: results of the Joint Utilization of Medications to Block Platelets Optimally (JUMBO)-TIMI 26 trial.

Wiviott SD, Antman EM, Winters KJ, Weerakkody G, Murphy SA, Behounek BD, Carney RJ, Lazzam C, McKay RG, McCabe CH, Braunwald E; JUMBO-TIMI 26 Investigators.

Circulation. 2005 Jun 28;111(25):3366-73. Epub 2005 Jun 20.

PMID:
15967851
[PubMed - indexed for MEDLINE]
Free Article
16.

Antiplatelet therapy for atherothrombotic disease: how can we improve the outcomes?

Moser M, Bode C.

J Thromb Thrombolysis. 2010 Aug;30(2):240-9. doi: 10.1007/s11239-010-0488-y. Review.

PMID:
20467788
[PubMed - indexed for MEDLINE]
17.

Balancing the benefits and risks of antiplatelet agents in patients with non-ST-segment elevated acute coronary syndromes and undergoing percutaneous coronary intervention.

Saucedo JF.

J Thromb Thrombolysis. 2010 Aug;30(2):200-9. doi: 10.1007/s11239-010-0444-x. Review.

PMID:
20111983
[PubMed - indexed for MEDLINE]
18.

Platelet ADP-receptor antagonists for cardiovascular disease: past, present and future.

Raju NC, Eikelboom JW, Hirsh J.

Nat Clin Pract Cardiovasc Med. 2008 Dec;5(12):766-80. doi: 10.1038/ncpcardio1372. Epub 2008 Oct 28. Review.

PMID:
18957959
[PubMed - indexed for MEDLINE]
19.

Novel antiplatelet therapy in acute coronary syndromes: what is new in the pipeline?

Müller KA, Geisler T.

Curr Vasc Pharmacol. 2012 Sep;10(5):606-18.

PMID:
22724478
[PubMed - indexed for MEDLINE]
20.

Platelet function testing and implications for clinical practice.

Collet JP, Montalescot G.

J Cardiovasc Pharmacol Ther. 2009 Sep;14(3):157-69. doi: 10.1177/1074248409339309. Review.

PMID:
19721130
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk